Frost & Sullivan Acknowledges the Potential of Apervita’s Platform to Rapidly Spread Knowledge Throughout Healthcare
Apervita creates a data and analytics ‘sharing community’ that enables stakeholders to come together to resolve issues in the healthcare system
Download free report here
See the analytics catalog and read the community blog here
Based on its recent analysis of the health data analytics market, Frost & Sullivan recognizes Apervita with the 2015 North American Frost & Sullivan Award for New Product Innovation. Apervita is an innovative new IT vendor providing a flexible, affordable and highly scalable analytics platform designed to address the growing need for analytics among healthcare organizations. Its self-service, HIPAA-compliant platform empowers healthcare organizations to easily create, publish and distribute their internally developed knowledge and analytics tools, as well as purchase analytics and data from other health enterprises through the Apervita Market.
The key to Apervita's model is that the platform enables health enterprises to rapidly launch hundreds of new insights to their organization, capitalizing on all data sources and delivering it into any user system. This approach makes insight widely available while avoiding the fragmentation of analytics across silos. It creates an environment where health IP can be autonomously created, executed and enhanced. Once the organization’s data is streamed through secure application program interfaces (APIs), hundreds of analytics from Apervita’s rapidly expanding catalog can be quickly deployed to any system, such as an EMR or BI visualization tool.
“The Apervita Market is unique in the industry and consists of a variety of game-changing tools and content, including medical data sets, algorithms and quality measures published by leading industry experts,” said Frost & Sullivan Research Analyst Nancy Fabozzi. “Among the many applications are predictive analytics to identify those most at risk of chronic disease and better manage them, target patients most at risk for early readmissions, reduce hospital acquired infections, and prevent claims denials. It also provides the ability to create dashboards for data visualization, and self-service tools that facilitate authoring and reporting on standard quality measures.”
A unique difference with Apervita is that analytics are separated from the underlying data, rather than the traditional SQL approach of embedding a data model and structure into analytics. The author of the analytics does not need any prior knowledge of the data source, so analytics become portable and can be easily deployed against any health data or system. The platform uses a secure, private, and robust cloud-based technology infrastructure. Every server is 100 percent dedicated and fully managed by the company. Its unified platform runs on the document-oriented MongoDB, which eases common problems associated with legacy database technology. In addition, MongoDB tackles head on the issue of integrating large volumes of diverse data sources—a key technology consideration for healthcare organizations—while offering massive scalability, which is vital as more and more analytics are deployed.
Since its launch in early 2015, the Apervita Market has grown rapidly and today consists of more than 250 member-contributed analytics, with hundreds more soon to be published. With regard to analytics for quality measures, Apervita, in partnership with the Mayo Clinic, allows users to easily import and disseminate quality measures, such as measures from the Centers for Medicare and Medicaid (CMS). The Apervita measure editor helps quality measures be developed and maintained centrally by experts, then tested and executed by many. It lets anyone, through a straightforward point and click interface, to create computable quality measures.
One of the key incentives for healthcare organizations to adopt Apervita is that the company does not own the data or intellectual property. Unlike many other analytic vendors that demand secondary use rights and resell data, ownership and rights to the intellectual property on the Apervita platform remain with the owner.
“Apervita has done a remarkable job in developing an innovative new product to address customer needs in the data analytics market. Its analytics platform is uniquely positioned for sustained success because it addresses the core issues that customers care about: functionality, scalability and affordability,” said Frost & Sullivan Global President & Managing Partner Krishna Srinivasan.
For these unique benefits and technology, Frost & Sullivan is pleased to present Apervita with the 2015 North American Frost & Sullivan Award for New Product Innovation in the health data analytics market.
Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it offers customers, which, in turn, increases customer acquisition and overall market penetration potential.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
Apervita is the leading platform and marketplace for computable health. With Apervita, health enterprises are unlocking the world’s health knowledge and transforming it into valuable insights that are easily shared with anyone and any user system. By making analytics and data pervasive, Apervita empowers health professionals to deliver better care, everywhere.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?